Neoleukin Therapeutics, Inc.
NLTX News Today: Stay Updated with the Latest Neoleukin Therapeutics, Inc. News in Real Time
Find NLTX news now at Meyka AI. Stay informed with the latest Neoleukin Therapeutics, Inc. stocks updates, including price news, market analysis, and expert insights.
Neurocrine Biosciences Close to $2.5B Acquisition of Soleno Therapeutics
We’re seeing a major move in biotech today. Neurocrine Biosciences is close to completing a deal to acquire Soleno Therapeutics in a transaction worth more than $2.5 billion, potentially rising to about $2.9 billion in cash. This deal is one of the most notable biotech acquisitions so far in 2026, and it aligns with Neurocrine’s growth strategy…
Down 50% to C$0.005: BRAS.CN Nordique Resources Inc. (CNQ) 06 Apr 2026, key risk
BRAS.CN stock down 50% to C$0.005 on 06 Apr 2026; we examine valuation, liquidity and Meyka forecast
6597.T stock up 43% to JPY 3000 on JPX close 06 Apr 2026: strong volume may sustain gains
6597.T stock jumps 43% to JPY 3000 on JPX close 06 Apr 2026; volume surge and fundamentals examined
€0.05 intraday low: VisionSys AI (0T8B.F, XETRA) 06 Apr 2026 watch rebound
Intraday update for 0T8B.F stock: €0.05 low, heavy volume; oversold bounce setup and Meyka AI forecast
Pre-market $452.07: ISRG Intuitive Surgical NASDAQ 06 Apr 2026: AI +29.53%
Pre-market ISRG stock update: price $452.07, PE 57.37, Meyka AI forecast +29.53% annual upside
NGD.TO New Gold (TSX) C$12.16 pre-market Apr 06 2026: heavy volume, watch momentum
NGD.TO stock pre-market at C$12.16 on Apr 06 2026; volume surging, EPS C$1.48, PE 8.22, model forecasts C$20.11
GNRSU stock drops to $0.000001 on 06 Apr 2026: low liquidity raises risk
GNRSU stock falls to $0.000001 on 06 Apr 2026; analysis, Meyka AI grade B, liquidity risks and forecast
FSLR.SW First Solar +143.99% to CHF153.40 pre-market (SIX) Apr 2026: Target range
Pre-market FSLR.SW stock update: First Solar jumps to CHF153.40 on Apr 2026; analyst targets, valuation and Meyka AI forecast inside
SPOD.CN Spod Lithium Corp. (CNQ) drops 50% to C$0.005 on 06 Apr 2026: liquidity and valuation risks rise
SPOD.CN stock fell 50% to C$0.005 on 06 Apr 2026; quick take, grade, and a C$0.02 monthly forecast for traders